Skip to main content
. 2004 Jun;57(6):591–597. doi: 10.1136/jcp.2003.013508

Table 7.

Survival and combination of CD34 and tumour invasion in patients with NSCLC

Groups Median survival (months) 95% CI p Value
A (CD34+/TVI+) 15 7 to 23 <0.0001
B (CD34−/TVI+, CD34+/TVI−) 44 6 to 82
C (CD34−/TVI−) 116 84 to 148

CI, confidence interval; NSCLC, non-small cell lung cancer; TVI, tumour vessel invasion.